Keyphrases
Variable Response
100%
Colitis
100%
Experimental Colitis
100%
VSL#3
83%
Lactobacillus Strains
66%
Sulfonic Acid
50%
Iodoacetamide
50%
Dinitrobenzene
50%
Acid Activation
33%
Lesion Area
33%
Myeloperoxidase
33%
Inflammatory Bowel Disease
33%
Prostaglandin E2
33%
Nitric Oxide Synthase Activity
33%
Probiotic Preparation
33%
Probiotic Bacteria
33%
Immune Response
16%
Mucosa
16%
Protective Effect
16%
Treatment Group
16%
Beta-blockers
16%
Colon
16%
Pouchitis
16%
Rat Colon
16%
Polymerase Chain Reaction Amplification
16%
Sulfhydryl
16%
Sulfhydryl Compounds
16%
Wet Weight
16%
Intestinal Flora
16%
Medicine and Dentistry
Colitis
100%
Experimental Colitis
100%
Probiotics
100%
VSL3
83%
Lactobacillus
66%
Iodoacetamide
50%
Nitrobenzene Derivative
50%
Sulfonic Acid Derivative
50%
Colon
33%
Nitric Oxide Synthase
33%
Prostaglandin E2
33%
Thiol Derivative
33%
Myeloperoxidase
33%
Mucosa
16%
Pouchitis
16%
Patient with Inflammatory Bowel Disease
16%
Intracolonic Drug Administration
16%
Polymerase Chain Reaction
16%
Treatment Group
16%
Inflammatory Bowel Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Colitis
100%
Experimental Colitis
100%
VSL3
83%
Lactobacillus
66%
Sulfonic Acid
50%
Iodoacetamide
50%
Nitrobenzene Derivative
50%
Nitric Oxide Synthase
33%
Prostaglandin E2
33%
Inflammatory Bowel Disease
33%
Thiol Derivative
33%
Myeloperoxidase
33%
Intestine Flora
16%
Ileitis
16%
Treatment Group
16%